Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Guarda

16 clinical trials in Guarda, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Guarda at a glance
16
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

16 trials in Guarda

Open in trial search
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Alogliptin
  • Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Psoriatic arthropathy

Not recruiting
Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Giant cell arteritis

Not recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Doxycycline Hyclate
  • Sponsor:Polypid Ltd.
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Solfarcos Solucoes Farmaceuticas E Cosmeticas Lda.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Guarda

What the registry says about research in the country

01 Autoimmune Conditions

Clinical research focusing on innovative treatments for Sjögren's Syndrome and Systemic Lupus Erythematosus, evaluating new therapeutic approaches to manage these chronic conditions.

  • Sjögren's Syndrome Management
  • Lupus Treatment Innovations
  • Autoimmune Disease Therapy

Studies aim to improve quality of life and reduce disease activity in patients with autoimmune disorders.

02 Respiratory Medicine

Breakthrough research in treating severe asthma and COPD, with trials evaluating novel biologics and targeted therapies for patients with specific disease phenotypes.

  • Eosinophilic Asthma Treatment
  • COPD Management
  • Respiratory Disease Control

Focus on developing long-acting treatments to improve respiratory function and reduce exacerbations.

03 Oncology & Gastroenterology

Advanced studies in metastatic colorectal cancer treatment and research on non-alcoholic steatohepatitis, exploring targeted therapies and innovative treatment approaches.

  • HER2+ Colorectal Cancer Therapy
  • NASH Treatment Development
  • Liver Disease Management

Trials aim to improve survival rates and develop effective treatments for complex digestive system conditions.

04 Rheumatology

Innovative research on Rheumatoid Arthritis, Psoriatic Arthritis, and Giant Cell Arteritis, testing new therapeutic options and treatment combinations.

  • Advanced RA Treatments
  • Psoriatic Disease Management
  • Arteritis Therapy

Studies focus on improving disease control and reducing inflammation in rheumatic conditions.

05 Infection Prevention

Clinical studies addressing surgical site infections and Clostridioides difficile prevention, developing new approaches to combat healthcare-associated infections.

  • Post-Surgical Infection Prevention
  • C. difficile Treatment
  • Antimicrobial Strategies

Research aims to reduce infection rates and improve patient outcomes following medical procedures.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.